by EmpathiCSubstanceS | Feb 2, 2022 | Cancer, Cannabis Marijuana, CBC, Chronic Pain, Cluster Headaches, Depression, DMT, MDMA Sassafras Molly, OCD
From the late 1950s to the early 1970s a novel experimental paradigm was employed to use hallucinogenic drugs to address the existential anxiety, depression and demoralization often experienced by individuals suffering from terminal cancer. In spite of highly...
by EmpathiCSubstanceS | Feb 2, 2022 | MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, Pain, Parkinson's Disease, PTSD
A personal account of how hallucinogens have influenced her career; and we pass on some advice for first-year undergraduates as they begin their journey in psychology. I am so glad I took LSD – and mescaline, and psilocybin, and even DMT which must surely have given...
by EmpathiCSubstanceS | Feb 2, 2022 | Bipolar Disorder, LSD, MDMA Sassafras Molly, OCD, Pain, Psilocybin Magic Mushroom
On 5 May 1953 the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley consumed the drug in his California home under the direct supervision of psychiatrist...
by EmpathiCSubstanceS | Jan 14, 2022 | Neuropathy, NN-Dimethyltryptamine, OCD, San Pedro Mescaline
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving the way for a...
